because of its biodegradable
property, PLA is expected to be used for medical devices, such as controlled drug
release matrices. It is known that the rate of hydrolytic degradation of PLA is strongly
affected by the degree of crystallinity. Therefore, it is well expected that the solidstate
structure including a crystalline lamellar organization plays an important role for
controlling the degradation rate.